23 stories tagged Medication Safety. Browse all of Side Effects
FDA found mold at one Chinese plant and relabeled raw drug at another, both supplying compounded GLP-1s. See what to ask your pharmacy.
UK officials seized 12,000 fake GLP-1 pens. See where fakes come from, why the US could see more, and how to check the pen in your hand.
Retatrutide isn't approved anywhere, yet it's sold online. See what JAMA found in black market vials and how to spot a safe pharmacy.
A $95 peptide vial had a brand, a shop and a lab report. See which signals are easy to fake and what a licensed pharmacy is really held to.
Some peptides are FDA-approved medicines and some "research" peptides are risky. A plain-language guide to telling safe sources from unsafe ones.
Lab testing finds many grey-market peptides miss their purity claims, with heavy metals and bacterial contamination in samples. Here is what to know.
We found no human study of wellness peptides like BPC-157 taken with a GLP-1. What the FDA's pending peptide policy would and wouldn't change.
The FDA removed 12 peptides from a restricted category in April 2026. What that means for access, safety, and your GLP-1 care.
New research links semaglutide to 42% fewer psychiatric hospitalizations. See what studies show about GLP-1 medications, depression, and anxiety.
Eli Lilly claims B12 in compounded GLP-1s creates an impurity. We break down what the data shows, what's missing, and whether you should worry.
Worried about GLP-1 side effects? Learn what’s common, how often it happens, and when symptoms usually start.
Research GLP-1 peptides are often sold online outside the medical system. Learn what they are, why they’re risky, and how to spot grey-market products
Retatrutide shows major Phase 3 weight-loss results but remains investigational. Learn what’s real in 2026 and why social ads can be misleading.
Curious about GLP-1 patches on TikTok? Learn what is real, what is hype, and how to stay safe with GLP-1 treatments that are actually FDA approved.
Learn what to expect before starting a GLP-1 — supplies, mindset, telehealth basics, safety tips, and how to prepare for your first dose.
Unsure about small ‘extra’ in your GLP-1 vial? Learn what’s normal, what’s safe, and when to call your provider — based on FDA and clinical guidance.
Your GLP-1 medication really can expire. Learn what expiration and beyond-use dates mean, when to discard, and how to keep injections safe.
FDA recalls compounded semaglutide and tirzepatide by ProRx LLC for sterility concerns. See if your vial’s affected and what to do next.
Missed your GLP-1 dose? Learn what happens in your body, how to safely make up or skip a dose, and why it’s important to talk to your provider.
Learn how compounding pharmacies work, why FDA oversight matters for GLP-1 safety, and what to check at local or telehealth pharmacies.
New oral GLP-1 pills may soon replace injections—but are they safe and effective? Learn what’s coming and how to avoid fake patches.
What happens after stopping GLP-1 meds—why rebound happens, what studies show, and how to keep your progress.
GLP-1 myths spread fast. Here’s the truth about Wegovy, Zepbound, side effects, “Ozempic face,” and more—backed by trusted sources.